Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
JIB
BioConferenceLive

2013 JIB Congress to Emphasize New Perspectives in Medical Biology

By BiotechDaily International staff writers
Posted on 15 Jul 2013
A new governance has been set up to organize the next Journées Internationales de Biologie (JIB; Paris, France), its 58th annual meeting of medical biologists, to be held November 13–15, 2013 at the CNIT Paris, La Défense. In order to place the congress as a key "laboratory agenda" professional event, JIB renews itself not only as a recurring gathering for the profession, but also as an opportunity to gain fresh, positive perspectives on one's daily practice in the laboratory.

In order to optimize attendee presence at the meeting, efficiency is emphasized in enabling participants in each area to gather, individually or collectively, in a productive manner. Medical biologists can find solutions in various missions (HR, quality, logistics, finance, etc.) and fields (hematology, virology, biochemistry, etc.) by their participation in the congress, the exhibition, and the JIB Awards. Discussions and exchanges between specialists take place on the "Paroles d’Experts.” The "Institutions Corner" brings together various authorities for the profession (regional associations, societies, orders, ministries, syndicates, or humanitarians). JIB is also committed to the new generation and has dedicated the "Recruitment Sphere" section with practical workshops to help facilitate access and integration of new biologists to the professional world.

The exhibition platform for launching innovations will present nearly 200 technological advances and solutions, of which 75% have a European and worldwide scope, and 78% are presented for the first time. Innovation is particularly visible at the "Innovation Gallery," and is further emphasized at the JIB Awards ceremony, provided for the second time after its success in 2012, now with six new categories: Procedures Improvement, Innovation Gallery, Quality and Accreditation, Emergency Biology and POC, Post Analytics Innovation, and the Jury’s Award.

The congress sessions mainly relate to the multidisciplinary aspect of medical biology, innovative laboratory equipment and technologies, and the role of biology in healthcare policies and organization. The inaugural session “Medical biology and screening policies” highlights biology in preventive and individualized medicine as the desired alternative to curative medicine. The session on “Nanotechnologies, first outcomes and perspectives in medical biology” presents an overview of the miniaturized technologies that are transforming diagnosis and follow-up methods. In parallel to the scientific sessions, the "Colloquium" offers working sessions to assist with various topics such as laboratory services, the medical biology laboratory in local health policies, and the evolution of the biomedical practice organization.

Related Links:

JIB - Journées Internationales de Biologie





comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: Microcomputed tomography images (top) and histology images (bottom) of the knees of mice fed a very high fat diet containing omega-3 fatty acid supplement (left) or only omega-6 fatty acids (right) after a knee injury. The omega-6 diet showed abnormal bone remodeling and calcified tissue formation in the joint (white arrow). The omega-6 diet also showed significant loss of cartilage (red staining, yellow arrowhead) and increased joint inflammation (Photo courtesy of Duke University).

Dietary Omega-3 Fatty Acids Moderate Severity of Osteoarthritis in a Mouse Model

Researchers working with an osteoarthritis (OA) obese mouse model found that the fat content of the animals' diet contributed more to the development or arrest of OA than did body weight.... Read more

Drug Discovery

view channel
Image: Molecular rendering of the crystal structure of parkin (Photo courtesy of Wikimedia Commons).

Cinnamon Feeding Blocks Development of Parkinson's Disease in Mouse Model

A team of neurological researchers has identified a molecular mechanism by which cinnamon acts to protect neurons from damage caused by Parkinson's disease (PD) in a mouse model of the syndrome.... Read more

Therapeutics

view channel

Vaccine Being Developed for Heart Disease Close to Reality

The world’s first vaccine for heart disease is becoming a possibility with researchers demonstrating significant arterial plaque reduction in concept testing in mice. Klaus Ley, MD, from the La Jolla Institute for Allergy and Immunology (LA Jolla, CA, USA), and a vascular immunology specialist, is leading the vaccine... Read more

Business

view channel

A Surge in IPOs Revitalize Investments for the Global Pharma and Biotech

Anti-infective drugs, oncology, and pharmaceutical contract laboratories attract the most investment up to now. The intensified private equity and venture capital (PEVC) deal activity in the global healthcare industry during the recession years, 2008–2010, witnessed a waning post-2010. However, the decline in deals... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.